Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Manufacturing source : Www.biospace.com save search
Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
BTCY | News | $1.48 1.8K
|
Manufacturing
|
| O: 7.5%
H: 0.0%
C: 0.0%
cardiac hospital system program pilot
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
EVO | News | $7.15 -1.24% -0.7% 950
|
Manufacturing
|
| O: 0.42%
H: 0.0%
C: 0.0%
partnership fibrosis
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
Published: 2024-04-18 (Crawled : 11:00) - biospace.com/
BPTS | News | $0.326 12.26% -1.18% 16K
|
Manufacturing
|
| O: 1.05%
H: 0.0%
C: 0.0%
obesity for study
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
Published: 2024-04-17 (Crawled : 16:00) - biospace.com/
HYPR | $0.81 -10.99% -12.35% 0
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -8.08%
first alzheimer’s care enroll therapy study
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVO | News | $7.15 -1.24% -0.7% 950
|
Manufacturing
|
| O: 1.0%
H: 0.0%
C: 0.0%
year for results
NRx Pharmaceuticals, Inc. Announces New Data on NRX-101
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NRXP 1 d | $3.02 -27.75% -38.18% 4.6K
|
Manufacturing
|
| O: -0.93%
H: 0.94%
C: -1.88%
nrx-101
Evotec welcomes Aurélie Dalbiez as Chief People Officer
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
EVO | News | $7.15 -1.24% -0.7% 950
|
Manufacturing
|
| O: 1.0%
H: 0.0%
C: 0.0%
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
Published: 2024-04-16 (Crawled : 17:00) - biospace.com/
IINN | $1.8099 12K
|
Manufacturing
|
| O: 0.0%
H: 1.55%
C: 0.0%
art100 device for
Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
PPCB | $0.001 -28.57% -41.86% 0
|
Manufacturing
|
| O: 0.0%
H: 14.29%
C: -7.14%
patent cancer biopharma for grant
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
NVNO | $4.78 -0.42% 2.04% 0
|
Manufacturing
|
| O: -1.22%
H: 0.0%
C: -2.06%
symposium topline medical trial
Scientific Industries Announces Appointment of Industry Leader Michael Blechman as New Board Member
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
SCND | $1.3 -5.8% 0.5% 0
|
Manufacturing
| Email alert
Add to watchlist
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
Published: 2024-04-15 (Crawled : 23:00) - biospace.com/
NVOS | $0.4664 -8.53% -8.12% 20K
|
Manufacturing
|
| O: 2.31%
H: 4.11%
C: -1.08%
year sciences financial results
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
Published: 2024-04-15 (Crawled : 23:00) - biospace.com/
CCEL | $7.37 9.19% 0.0% 7
|
Manufacturing
|
| O: -4.72%
H: 5.68%
C: 3.06%
first blood financial results
IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
ICCM | $1.23 -4.65% -4.03% 8K
|
Manufacturing
| Email alert
Add to watchlist
free breast cancer medical trial results
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
NRXP 1 d | $3.02 -27.75% -38.18% 4.6K
|
Manufacturing
|
| O: 1.17%
H: 0.29%
C: -5.41%
htx-100 pharmaceuticals
Invivyd Announces CEO TransitionJeremy Gowler appointed Interim CEO
Published: 2024-04-12 (Crawled : 13:30) - biospace.com/
IVVD | $2.35 -5.24% -4.86% 0
|
Manufacturing
|
| O: 1.16%
H: 0.0%
C: 0.0%
ceo
Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.51 0.75% -3.03% 1.5K
|
Manufacturing
|
| O: 3.23%
H: 0.16%
C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
IINN | $1.8099 12K
|
Manufacturing
|
| O: 2.06%
H: 19.19%
C: 5.05%
bloodstream infections results show growth study
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
Published: 2024-04-08 (Crawled : 22:00) - biospace.com/
BPTS | News | $0.326 12.26% -1.18% 16K
|
Manufacturing
|
| O: -3.31%
H: 0.0%
C: -4.69%
bio101 obesity study
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
RWOD | $12.0 50.06% 3.9M
|
n/a
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
CARV 4 | $1.77 11.32% 8.5K
|
Finance
BROG | $1.23 10.81% 320K
|
Finance
PARA | $12.03 9.66% 5.8M
|
Information
ADAP | $0.98 9.08% 240K
|
Health Technology
POAI A | $1.25 8.69% 16K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.